intrathecal ropivacaine complex with dexmedetomidine in cesarean section surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800014454

Enrollment

Unknown

Registered

2018-01-15

Start date

2018-02-01

Completion date

Unknown

Last updated

2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean section

Interventions

Ropivacaine group:none

ropivacaine and dexmedetomidine 3µg group:dexmedetomidine 3µg

Ropivacaine and dexmedetomidine 5µg:dexmedetomidine 3µg

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: elective cesarean section in patients undering spinal anesthesia

Exclusion criteria

Exclusion criteria: combined with serious heart and lung ,liver and kidney desease, mental disorders, epiiepsy history,spinal anesthesia contraindiction

Design outcomes

Primary

Measure	Time frame
sensory block plane;VAS;Apgar score;umbilical cord blood PH;adverse events during anesthesia;	—

Countries

China

Contacts

Public ContactYanzhuo Zhang

Department of Anesthesiology, the second Affiliated Hospital of Harbin Medical University

zhangyanzhuo625@sina.com+86 18686856500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026